Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
-18.27%
↑ 77% above average
Average (9y)
-78.03%
Historical baseline
Range
High:-4.40%
Low:-217.48%
CAGR
+0.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -18.27% | +61.6% |
| 2023 | -47.59% | +16.3% |
| 2022 | -56.87% | -473.9% |
| 2021 | -9.91% | -125.2% |
| 2020 | -4.40% | +97.6% |
| 2019 | -180.03% | -1.0% |
| 2018 | -178.21% | +18.1% |
| 2017 | -217.48% | -332.5% |
| 2016 | -50.28% | -192.1% |
| 2015 | -17.22% | - |